Recent Press Releases

UNITED STATES DEPARTMENT OF JUSTICE CLOSES INVESTIGATION INTO PLATO CLINICAL TRIAL FOR BRILINTA

UNITED STATES DEPARTMENT OF JUSTICE CLOSES INVESTIGATION INTO PLATO CLINICAL TRIAL FOR BRILINTA 19 August 2014 AstraZeneca today announced that it has received confirmation from the United States...

FDA Grants Tentative Approval for Lilly and Boehringer Ingelheim's Basaglar™ (insulin glargine injection)

FDA Grants Tentative Approval for Lilly and Boehringer Ingelheim's Basaglar™ (insulin glargine injection) INDIANAPOLIS and RIDGEFIELD, Conn., Aug. 18, 2014 /PRNewswire/ -- The U.S. Food and...

Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion

Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion The contract development and manufacturing organisation, Recipharm AB has signed an agreement to acquire Milan based...

Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company

JERUSALEM, August 19, 2014 /PRNewswire/ --

Basilea appoints Chief Commercial Officer

Basilea appoints Chief Commercial Officer BASEL, Switzerland, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that it has appointed David Veitch as Chief...

NICE appraisal of earlier treatment with abiraterone for prostate cancer

In final draft guidance published today NICE has not recommended abiraterone for prostate cancer in people who received hormone therapy (androgen deprivation) but whose disease has spread, who have...

FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer

FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer August 14, 2014 The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to...

FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer

FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer Basel, 15 August 2014 Avastin is the first biologic medicine approved in combination with chemotherapy to...

NICE PROVISIONALLY RECOMMENDS GILEAD'S NEW HEPATITIS C TREATMENT SOVALDI® (SOFOSBUVIR) FOR USE IN ENGLAND & WALES

NICE PROVISIONALLY RECOMMENDS GILEAD'S NEW HEPATITIS C TREATMENT SOVALDI® (SOFOSBUVIR) FOR USE IN ENGLAND & WALES Cambridge, UK, August 15, 2014 – Gilead Sciences welcomes provisional...

Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy

Firm also Comments on Failed Kyprolis® Clinical Trial

MARLBOROUGH, Mass., Aug.

Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals

Merkerson Visits Dallas, Texas on August 14 With America's Diabetes Challenge: Get to Your Goals Program

WHITEHOUSE STATION, N.J.,

Advisory Committee on Immunization Practices Votes to Recommend Pfizer's Prevnar 13® Vaccine in Adults Aged 65 Years and Older

Wednesday, August 13, 2014 - 5:42pm EDT Pfizer Inc. (NYSE:PFE) today announced that the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP)...

Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis® In Patients With Relapsed And Advanced Refractory Multiple Myeloma

THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., Aug. 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that the Phase 3 clinical...

Merck Statement regarding Role of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults

Merck Statement regarding Role of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults WHITEHOUSE STATION, N.J., Aug 13, 2014...

Foster announces 348 new jobs and £54m investment by Almac Group

Foster announces 348 new jobs and £54m investment by Almac Group Enterprise, Trade and Investment Minister Arlene Foster has announced that the Almac Group is investing over £54 million...